In contrast to invasive colorectal carcinomas that develop in typical exophytic adenoma-carcinoma sequences, some invasive cancers may evolve from flat mucosal dysplastic lesions. Despite their relatively small size, these flat colorectal lesions are often associated with high-grade dysplasia and may show an aggressive clinical course. To delineate the genetic pathways in the clonal evolution of these tumors, multiple foci were microdissected from 13 cases and the allelic deletions of 15 chromosomal arms were analysed. Loss of heterozygosity (LOH) was detected most frequently on 17p (77%), followed by 18q (69%), and 5q (54%). In five cases with concomitant low-grade adenomas, only one case showed LOH in low-grade adenoma foci. In high-grade dysplasia with/without submucosal invasion, early and homogeneous LOH of one to several chromosomal arms was detected. Overall, homogeneous and thus early LOH were most frequently detected on 17p (seven of 10 cases with 17p LOH), followed by 3p (two of three cases with 3p LOH), and 5q (four of seven cases with 5q LOH). In addition to homogeneous LOH, the LOH patterns observed in different portions of dysplasias and invasive cancers in individual cases identified several different genetic patterns of tumour progression, either with linear or branching (divergent) trees. Positive immunostaining for p53 was detected in 10 of the 13 cases; of these, five cases were concomitant with 17p LOH in all of the microdissected foci, four cases were concomitant with 17p LOH in a majority of foci and, one case showed retention of 17p. Except for the flat configuration and early 17p LOH, genetic heterogeneity in the flat high-grade dysplastic foci was found to be similar to genetic chaos in the late dysplastic and preinvasive stages of exophytic adenoma. These findings suggest a potentially aggressive course for these neoplasms.

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1122DOI Listing

Publication Analysis

Top Keywords

17p loh
16
loh
12
cases concomitant
12
cases
9
loss heterozygosity
8
clonal evolution
8
flat colorectal
8
invasive cancers
8
high-grade dysplasia
8
chromosomal arms
8

Similar Publications

Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.

Biomed Pharmacother

April 2024

Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia. Electronic address:

Article Synopsis
  • Tumour suppressor genes are crucial in the development of lung cancer, which is a common type of cancer that often shows resistance to initial treatment.
  • Extensive research has been focused on understanding how mutations in these genes lead to cancer progression and treatment failure, particularly looking at specific chromosomal areas vulnerable to loss of heterozygosity (LOH) due to genetic and environmental factors.
  • The review aims to provide insight into the molecular mechanisms behind these alterations and to inspire future research efforts for more effective lung cancer therapies.
View Article and Find Full Text PDF

Molecular landscape of proliferative verrucous leukoplakia: a systematic review.

Br J Oral Maxillofac Surg

February 2024

Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Institute for Life Sciences, University of Southampton, Southampton, UK.

Article Synopsis
  • Proliferative verrucous leukoplakia (PVL) is a rare oral condition with a potential to evolve into oral cancers, lacking predictive biomarkers for its progression.
  • A review of 685 cases revealed PVL’s genomic profile includes initial high loss of heterozygosity (LOH) and low copy number alterations, with later mutations found in specific genes but no TP53 mutations.
  • Differences in LOH and specific chromosomal deletions and amplifications suggest similarities with oral verrucous carcinoma (OVC) and oral squamous cell carcinoma (OSCC), indicating a need for further research to clarify PVL's genomic landscape.
View Article and Find Full Text PDF

Background: Recently, HER2-negative breast cancers have been reclassified by protein expression into 'HER2-low' and 'HER2-zero' subgroups, but the consideration of HER2-low breast cancer as a distinct biological subtype with differing prognoses remains controversial. By contrast, non-neutral copy number alteration (CNA) status is associated with inferior survival outcomes compared to CNA-neutral breast cancer, providing an alternative approach to classification.

Methods: Here, we investigated the molecular landscape of non-metastatic HER2-negative BCs in relation to CNA status to elucidate biological differences.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the impact of the t(11;14) genetic anomaly in multiple myeloma patients to guide future treatment strategies.
  • Researchers examined data from 74 patients with t(11;14), comparing them to two other groups with different genetic profiles (IgH HR-MM and Hyperdiploid-MM), finding no significant differences in demographics or initial treatment patterns.
  • While overall progression-free survival was similar across groups, patients with t(11;14) showed poorer outcomes, highlighting the potential for using targeted therapies like venetoclax to improve treatment effectiveness for these patients.
View Article and Find Full Text PDF

Background: Research suggests physicians may harbour paternalistic attitudes towards people with intellectual and developmental disabilities and lack the knowledge and skills to work with them. This study examined the impact of a brief intellectual and developmental disability curriculum intervention on these outcomes.

Methods: First-year medical students completed a pre-post questionnaire on attitudes and knowledge of intellectual and developmental disabilities in conjunction with a curriculum (a virtual tour of a developmental service site; panel discussions; tutorial presentations).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!